Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): Early experience

Clinical Orthopaedics and Related Research

Volumn 467, Issue 12, 2009, Pages 3230-3238

  Dohin, Bruno ^a   Dahan Oliel, Noémi ^b   Fassier, François ^b   Hamdy, Reggie ^b  

^a UNIVERSITÉ LYON 1   (France)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; OSTEOGENIC PROTEIN 1;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALLERGIC REACTION; BONE PAIN; BONE RADIOGRAPHY; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONFERENCE PAPER; CONGENITAL PSEUDARTHROSIS; DRUG SAFETY; FEMALE; FOLLOW UP; FRACTURE; FRACTURE HEALING; HEALING; HETEROTOPIC OSSIFICATION; HUMAN; INFECTION; INFLAMMATION; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDARTHROSIS; SCHOOL CHILD; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WEIGHT BEARING;

EID: 70449526275     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-009-0967-7     Document Type: Conference Paper

References (35)

1. American Academy of Orthopaedic Surgeons. BMPs and cancer: is the risk real? Available at: http://www.aaos.org/news/aaosnow/may08/research7.asp. Accessed August 25, 2008.
2. D Anticevic M Jelic S Vukicevic 2006 Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report J Pediatr Orthop B. 15 220 221 16601593
3. TW Axelrad B Steen DW Lowenberg WR Creevy TA Einhorn 2008 Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients J Bone Joint Surg Br. 90 1617 1622 10.1302/0301-620X.90B12.20975 1:STN:280:DC%2BD1cjnsVGhtQ%3D%3D 19043134
4. B Bax J Wozney D Ashhurst 1999 Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia Calcif Tissue Int. 65 83 89 10.1007/s002239900662 1:CAS:528:DyaK1MXktleru7w%3D 10369739 (Pubitemid 29293533)
5. JT Buijs NV Henriquez PGM van Overveld G van der Horst I Que R Schwaninger C Rentsch P ten Dijke A-M Cleton-Jansen K Driouch R Lidereau R Bachelier S Vukicevic P Clezardin SE Papapoulos MG Cecchini CWGM Lowik G van der Pluijm 2007 Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer Cancer Res. 67 8742 8751 10.1158/0008-5472. CAN-06-2490 1:CAS:528:DC%2BD2sXhtVCit7vK 17875715 (Pubitemid 47437450)
6. JT Buijs CA Rentsch G van der Horst PGM van Overveld A Wetterwald R Schwaninger NV Henriquez P ten Dijke F Borovecki R Markwalder GN Thalmann SE Papapoulos RCM Pelger S Vukicevic MG Cecchini CWGM Lowik G van der Pluijm 2007 BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo Am J Pathol. 171 1047 1057 10.2353/ajpath.2007.070168 1:CAS:528:DC%2BD2sXhtV2murfJ 17724140 (Pubitemid 47441001)
7. KJ Burkhart PM Rommens 2008 Intramedullary application of bone morphogenetic protein in the management of a major bone defect after an Ilizarov procedure J Bone Joint Surg Br. 90 806 809 10.1302/0301-620X.90B6.20147 1:STN:280:DC%2BD1czntFKgsQ%3D%3D 18539677 (Pubitemid 351859813)
8. FC den Boer JAM Bramer TJ Blokhuis EJ Van Soest JMGT Jenner P Patka FC Bakker EH Burger HJTM Haarman 2002 Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fracture Bone. 31 158 164 10.1016/S8756-3282(02)00816-5 (Pubitemid 34754442)
9. R Dimitriou E Tsiridis I Carr H Simpson PV Giannoudis 2006 The role of inhibitory molecules in fracture healing Injury. 37S S20 S29 10.1016/j.injury.2006.02.039 (Pubitemid 44316774)
10. TA Einhorn 2003 Clinical applications of recombianat human BMPs: early experience and future development J Bone Joint Surg Am. 85 82 88 12925614
11. L Fabeck D Ghafil M Gerroudj R Baillon P Delincé 2006 Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia J Bone Joint Surg Br. 88 116 118 1:STN:280:DC%2BD2Mnnslehsw%3D%3D 16365133
12. GE Friedlaender CR Perry JD Cole SD Cook G Cierny GF Muschler GA Zych JH Calhoun AJ LaForte S Yin 2001 Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions J Bone Joint Surg Am. 83 S151 158 11314793
13. RG Geesink NH Hoefnagels SK Bulstra 1999 Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect J Bone Joint Surg Br. 81 710 718 10.1302/0301-620X.81B4.9311 1:STN:280:DyaK1MzptFeqsA%3D%3D 10463751
14. PV Giannoudis H Dinopoulos E Tsiridis 2005 Bone substitutes: an update Injury. 36 S20 S27 10.1016/j.injury.2005.07.029 16188545
15. PV Giannoudis NK Kanakaris TA Einhorn 2007 Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence Osteoporos Int. 18 1565 1581 10.1007/s00198-007-0441-x 1:STN:280:DC%2BD2snhslSltA%3D%3D 17694399 (Pubitemid 47620320)
16. S Govender C Csimma HK Genant A Valentin-Opran Y Amit R Arbel H Aro D Atar M Bishay MG Borner P Chiron P Choong J Cinats B Courtenay R Feibel B Geulette C Gravel N Haas M Raschke E Hammacher D van der Velde P Hardy M Holt C Josten RL Ketterl B Lindeque G Lob H Mathevon G McCoy D Marsh R Miller E Munting S Oevre L Nordsletten A Patel A Pohl W Rennie P Reynders PM Rommens J Rondia WC Rossouw PJ Daneel S Ruff A Ruter S Santavirta TA Schildhauer C Gekle R Schnettler D Segal H Seiler RB Snowdowne J Stapert G Taglang R Verdonk L Vogels A Weckbach A Wentzensen T Wisniewski 2002 Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients J Bone Joint Surg Am. 84 2123 2134 10.1302/0301-620X.84B5.12795 12473698
17. AR Hallahan JI Pritchard RAS Chandraratna RG Ellenbogen JR Geyer RP Overland AD Strand SJ Tapscott JM Olson 2003 BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect Nat Med. 9 1033 1038 10.1038/nm904 1:CAS:528:DC%2BD3sXlvV2ju7c%3D 12872164 (Pubitemid 37021783)
18. M-Y Hsu S Rovinsky S Penmatcha M Herlyn D Muirhead 2005 Bone morphogenetic proteins in melanoma: angel or devil? Canc Metastasis Rev. 24 251 263 10.1007/s10555-005-1575-y 1:CAS:528:DC%2BD2MXls1agsb8%3D (Pubitemid 40931929)
19. Y Katsuno A Hanyu H Kanda Y Ishikawa F Akiyama T Iwase E Ogata S Ehata K Miyazono T Imamura 2008 Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway Oncogene. 27 6322 6333 10.1038/onc.2008.232 1:CAS:528:DC%2BD1cXht1Ont7fM 18663362
20. S Kujala V Vähäsarja W Serlo 2008 Jalovaara P. Treatment of congenital pseudarthrosis of the tibia with native bovine BMP Acta Orthop Belg. 74 132 136
21. FN Kwong JA Hoyland AJ Freemont CH Evans 2009 Altered relative expression of BMPs and BMP inhibitors in cartilaginous areas of human fractures progressing towards nonunion J Orthop Res. 27 752 757 10.1002/jor.20794 1:CAS:528:DC%2BD1MXmtFaiurs%3D 19058174
22. JM Lane 2001 BMPs: why are they not in everyday use? J Bone Joint Surg Am. 83 S161 S162 11314797
23. FY Lee SM Sinicropi FS Lee MG Vitale DJ Roye IH Choi 2006 Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases J Bone Joint Surg Am. 88 627 633 10.2106/JBJS.D.02201 16510831
24. MD McKee 2005 Recombinant human bone morphogenic protein-7: applications for clinical trauma J Orthop Trauma. 19 S26 28 10.1097/00005131-200511101-00008 16479220
25. L Obert F Deschaseaux P Garbuio 2005 Critical analysis and efficacy of BMPs in long bones non-union Injury. 36 S38 S42 10.1016/j.injury.2005.07.033 16188548 (Pubitemid 41608589)
26. J Ristiniemi T Flinkkila P Hyvonen M Lakovaara H Pakarinen P Jalovaara 2007 RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation J Bone Joint Surg Br. 89 265 272 10.1302/0301-620X.89B2.18230 1:STN:280:DC%2BD2s7it1entg%3D%3D 17322450 (Pubitemid 46421481)
27. Stryker. OP-1 Implant for Fracture Repair. Available at: http://www.stryker.com/en-us/products/Orthobiologicals/Osteoinductive/OP-1/ index.htm. Accessed August 25, 2008.
28. M Termaat FC Den Boer FC Bakker P Patka HJTM Haarman 2005 Current concepts review Bone Morphogenetic Proteins. Development and clinical efficacy in the treatment of fractures and bone defects J Bone Joint Surg Am. 87 1367 1378 10.2106/JBJS.D.02585 1:STN:280:DC%2BD2M3osFGmuw%3D%3D 15930551 (Pubitemid 40756643)
29. M Urist 1965 Bone: formation by autoinduction Science. 150 893 899 10.1126/science.150.3698.893 1:STN:280:DyaF28%2FhvFekuw%3D%3D 5319761
30. B Vaibhav P Nilesh S Vikram C Anshul 2007 Bone morphogenetic protein and its application in trauma cases: a current concept update Injury. 38 1227 1235 10.1016/j.injury.2006.12.012 17307180 (Pubitemid 350046549)
31. K Watanabe H Tsuchiya K Sakurakichi K Tomita 2007 Bone transport using hydroxapatite loaded with bone morphogenetic protein in rabbits J Bone Joint Surg Br. 89 1122 1129 10.1302/0301-620X.89B8.19003 1:STN:280: DC%2BD2srhvFGjtQ%3D%3D 17785756 (Pubitemid 47492812)
32. RJ Westerhuis RL van Bezooijen P Kloen 2005 Use of bone morphogenetic proteins in traumatology Injury. 36 1405 1412 10.1016/j.injury.2005.02.047 1:STN:280:DC%2BD2Mnht1CrsA%3D%3D 16125704 (Pubitemid 41622166)
33. WKK Wu JJ Sung YC Wu ZJ Li L Yu CH Cho 2008 Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells Br J Pharmacol. 154 632 638 10.1038/bjp.2008.115 1:CAS:528:DC%2BD1cXmt1KqtLk%3D 18414391 (Pubitemid 351744945)
34. RW Wysocki MS Cohen 2007 Ectopic ossification of the triceps muscle after application of bone morphogenetic protein-7 to the distal humerus for recalcitrant nonunion: a case report J Hand Surg Am. 32 647 650 10.1016/j.jhsa.2007.03.001 17482003 (Pubitemid 46669831)
35. A Yasko J Lane E Fellinger V Rosen J Wozney E Wang 1992 The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats J Bone Joint Surg Am. 74 659 670 1:STN:280:DyaK38zisFSqtg%3D%3D 1378056